Cargando…

Meta-research metrics matter: letter regarding article “indirect tolerability comparison of Deutetrabenazine and Tetrabenazine for Huntington disease”

Here we discuss the report by Claassen and colleagues describing an indirect treatment comparison between tetrabenazine and deutetrabenazine for chorea in Huntington’s disease using individual patient data. We note the potential for discrepancies in apparently statistically significant findings, due...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodrigues, Filipe B., Duarte, Gonçalo S., Costa, João, Ferreira, Joaquim J., Wild, Edward J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698972/ https://www.ncbi.nlm.nih.gov/pubmed/29201386 http://dx.doi.org/10.1186/s40734-017-0067-x

Ejemplares similares

Tetrabenazine Versus Deutetrabenazine for Huntington's Disease: Twins or Distant Cousins?
por: Rodrigues, Filipe B., et al.
Publicado: (2017)

Indirect tolerability comparison of Deutetrabenazine and Tetrabenazine for Huntington disease
por: Claassen, Daniel O., et al.
Publicado: (2017)

Pharmacokinetics of Deutetrabenazine and Tetrabenazine: Dose Proportionality and Food Effect
por: Schneider, Frank, et al.
Publicado: (2020)

Real-World Adherence to Tetrabenazine or Deutetrabenazine Among Patients With Huntington’s Disease: A Retrospective Database Analysis
por: Claassen, Daniel O., et al.
Publicado: (2021)

Pharmacokinetic and Metabolic Profile of Deutetrabenazine (TEV‐50717) Compared With Tetrabenazine in Healthy Volunteers
por: Schneider, Frank, et al.
Publicado: (2020)

Tetrabenazine in the treatment of Huntington’s disease
por: Paleacu, Diana
Publicado: (2007)

Tetrabenazine is neuroprotective in Huntington's disease mice
por: Wang, Hongyu, et al.
Publicado: (2010)

Management of Huntington’s disease: role of tetrabenazine
por: de Tommaso, Marina, et al.
Publicado: (2011)

Effect of Tetrabenazine on Motor Function in Patients with Huntington Disease
por: Ferrara, Joseph M., et al.
Publicado: (2012)

Review of deutetrabenazine: a novel treatment for chorea associated with Huntington’s disease
por: Dean, Marissa, et al.
Publicado: (2018)

The Safety of Deutetrabenazine for Chorea in Huntington Disease: An Open-Label Extension Study
por: Frank, Samuel, et al.
Publicado: (2022)

On crushing of deutetrabenazine tablets
por: Knebel, Helena, et al.
Publicado: (2021)

Tetrabenazine: the first approved drug for the treatment of chorea in US patients with Huntington disease
por: Frank, Samuel
Publicado: (2010)

Correction:Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study
por: Frank, Samuel
Publicado: (2011)

Tetrabenazine as anti-chorea therapy in Huntington Disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators
por: Frank, Samuel
Publicado: (2009)

Deutetrabenazine in Tics Associated with Tourette Syndrome
por: Jankovic, Joseph, et al.
Publicado: (2016)

Use of Tetrabenazine in Huntington Disease Patients on Antidepressants or with Advanced Disease: Results from the TETRA-HD Study
por: Dorsey, Ray, et al.
Publicado: (2011)

Clinical Assessment of the Effect of Tetrabenazine on Functional Scales in Huntington Disease: A Pilot Open Label Study
por: Fekete, Robert, et al.
Publicado: (2012)

Benign Presentation Following Massive Deutetrabenazine Overdose
por: Obadeyi, Oluseyi, et al.
Publicado: (2021)

Case Report: Deutetrabenazine as an Adjunctive Treatment for Stuttering
por: Ha, Catherine A., et al.
Publicado: (2021)

Letter to the Editor Regarding Vaping Article
por: Spitz, Rabbi Yehuda
Publicado: (2019)

Structural Mechanisms for VMAT2 inhibition by tetrabenazine
por: Dalton, Michael P., et al.
Publicado: (2023)

A systematic review on treatment of tardive dyskinesia with valbenazine and deutetrabenazine
por: Patel, Rikinkumar S., et al.
Publicado: (2019)

Long-term safety and efficacy of deutetrabenazine for the treatment of tardive dyskinesia
por: Fernandez, Hubert H, et al.
Publicado: (2019)

Huntington’s Disease Clinical Trials Corner: June 2019
por: Rodrigues, Filipe B., et al.
Publicado: (2019)

Safety and Efficacy of Tetrabenazine and Use of Concomitant Medications During Long-Term, Open-Label Treatment of Chorea Associated with Huntington’s and Other Diseases
por: Shen, Vivienne, et al.
Publicado: (2013)

Retrospective Analysis of Healthcare Resource Use, Treatment Patterns, and Treatment-related Events in Patients with Huntington’s Disease–associated Chorea Initiated on Tetrabenazine
por: Sung, Victor W., et al.
Publicado: (2018)

Characterizing White Matter in Huntington's Disease
por: Gregory, Sarah, et al.
Publicado: (2019)

Letter to the editor regarding the article of Chen et al.
por: Islamoglu, Mehmet Sami, et al.
Publicado: (2022)

Treatment of Tardive Dyskinesia by tetrabenazine, clonazepam and vitamin E
por: Sharma, Himanshu
Publicado: (2009)

Dual Treatment of Hemichorea–Hemiballismus Syndrome with Tetrabenazine and Chemodenervation
por: Umeh, Chizoba C., et al.
Publicado: (2012)

Behaviour of Tetrabenazine in Acid Medium: Reassessment and Impact on Formulation
por: Ettouati, Laurent, et al.
Publicado: (2019)

Synthesis of Tetrabenazine and Its Derivatives, Pursuing Efficiency and Selectivity
por: Paek, Seung-Mann
Publicado: (2020)

Randomized controlled trial of deutetrabenazine for tardive dyskinesia: The ARM-TD study
por: Fernandez, Hubert H., et al.
Publicado: (2017)

Evaluation of Deutetrabenazine's Potential to Delay Cardiac Repolarization Using Concentration‐QTc Analysis
por: Schneider, Frank, et al.
Publicado: (2022)

Letter Regarding Article, "Biventricular Takotsubo Cardiomyopathy Associated with Epilepsy"
por: Madias, John E.
Publicado: (2016)

Differences in Dihydrotetrabenazine Isomer Concentrations Following Administration of Tetrabenazine and Valbenazine
por: Skor, Heather, et al.
Publicado: (2017)

Unique Case Reports of Tooth Sensitivity After Consuming Tetrabenazine
por: Daripa, Bob
Publicado: (2022)

Article-Level Metrics
por: Gasparyan, Armen Yuri, et al.
Publicado: (2021)

Response to Letter Regarding Article, "Biventricular Takotsubo Cardiomyopathy Associated with Epilepsy"
por: Hong, Ji Yeon
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0k99tfi5b7uga9rvn11fj7n5fa